Stock Events

Stock Events

Acorda Therapeutics (ACOR) Q3 2023 Earnings

13NovConfirmed

Q4 2022

Q1 2023

Q2 2023

Q3 2023

-7.55

-4.84

-2.14

0.57

Details

Expected EPS

N/A

Actual EPS

-7.16

Surprise EPS

-7.16

Surprise Percent

+∞%

Description

Acorda Therapeutics (ACOR) has reported earnings of -7.16 per share for Q3 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.